SEI Investments
EPZM

SEI Investments’s Epizyme, Inc EPZM Stock Holding History

SEI Investments’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,239
Closed -$201K – 2671
2021
Q2 		$201K Buy
+24,239
New +$204K ﹤0.01% 2446
2020
Q2 		– Sell
-28,369
Closed -$440K – 2466
2020
Q1 		$440K Sell
28,369
-1,337
-5% -$28.7K ﹤0.01% 1782
2019
Q4 		$731K Buy
+29,706
New +$441K ﹤0.01% 1767
2015
Q4 		– Sell
-15,372
Closed -$198K – 2742
2015
Q3 		$198K Buy
+15,372
New +$310K ﹤0.01% 1608

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

SEI Investments's EPZM Position: Q3 2021 in Review

SEI Investments sold out of Epizyme, Inc (EPZM) in Q3 2021, closing a stake of 24,239 shares — an estimated $201K sold.

SEI Investments first reported a position in EPZM in Q3 2015 and held it in 4 quarters. The position peaked at $731K in Q4 2019. 116 funds tracked by Wall St. Rank hold EPZM as of Q3 2021.

  • SEI Investments reported no remaining Epizyme, Inc position as of Q3 2021 after selling out during the quarter.
  • SEI Investments sold 24,239 Epizyme, Inc shares in Q3 2021, an estimated $201K.
  • SEI Investments first reported a position in Epizyme, Inc in Q3 2015 and held it in 4 quarters.
  • SEI Investments's Epizyme, Inc position peaked at $731K in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2021.

Based on SEI Investments's 13F filing for Q3 2021, filed 12 Nov 2021.